{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Forschner J"],"journal":["Frontiers in oncology"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12378509"],"repository":["biostudies-literature"],"pubmed_title":["Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation"],"pmcid":["PMC12378509"],"pubmed_authors":["Flatz L","Eigentler T","Garbe C","Forschner A","Bonzheim I","Amaral T","Huynh J","Seibel-Kelemen O","Reitmajer M","Forschner J","Ossowski S","Armeanu-Ebinger S","Schroeder C","Gschwind A"],"additional_accession":[]},"is_claimable":false,"name":"Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2026-05-10T04:21:36.108Z","creation":"2026-04-08T01:28:49.624Z"},"accession":"S-EPMC12378509","cross_references":{}}